ROTE WILLIAM E.
SEC insider (Form 3/4/5 filer). CIK 0001698262. Chief Research Officer at Travere Therapeutics, Inc. (TVTX). 29 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in SAN DIEGO, CA.
Companies ROTE WILLIAM E. has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Officer, Chief Research Officer
ROTE WILLIAM E.
CIK: 0001698262
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 16, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect65.1K shares at avg. $63.12$4.1M - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect55K shares at avg. $15.46$850K - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect47.7K shares at avg. $63.61$3.0M - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect350 shares at avg. $17.96$6K - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect57.5K shares at avg. $26.88$1.5M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect29K shares at avg. $62.66$1.8M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect270 shares at avg. $65.31$18K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect39K shares at avg. $25.25$985K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect39.7K shares at avg. $17.96$712K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect63.9K shares at avg. $61.99$4.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 65,104 | $63.12 | $4,109,397 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 55,000 | $15.46 | $850,300 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 47,746 | $63.61 | $3,037,247 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 350 | $17.96 | $6,286 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 57,500 | $26.88 | $1,545,600 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 29,021 | $62.66 | $1,818,317 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 270 | $65.31 | $17,634 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 39,000 | $25.25 | $984,750 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 39,650 | $17.96 | $712,114 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 63,907 | $61.99 | $3,961,851 | Direct |
1-10 of 29 transactions